Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Functional characterization of apolipoproteins in the HCV life cycle 2019
2018 Tet-inducible production of infectious zika virus from the full-length cdna clones of African-and Asian-lineage strains 2018
2018 Characterization of apolipoprotein C1 in hepatitis C virus infection and morphogenesis 2018
2018 Robust human and murine hepatocyte culture models of hepatitis B virus infection and replication 2018
2017 Attachment and postattachment receptors important for hepatitis C virus infection and cell-to-cell transmission 2017
2017 Identification of cellular genes and pathways important for tumorigenicity of hepatocellular carcinoma cell lines by proteomic profiling 2017
2017 TIM-1 promotes hepatitis C virus cell attachment and infection 2017
2016 Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a. 2016
2015 Oncogenic viruses and cancer 2015
2015 A Dual-Reporter System for Real-Time Monitoring and High-throughput CRISPR/Cas9 Library Screening of the Hepatitis C Virus 2015
2015 Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans 2015
2015 The serum very-low-density lipoprotein serves as a restriction factor against hepatitis C virus infection 2015
2013 Apolipoprotein E Mediates Attachment of Clinical Hepatitis C Virus to Hepatocytes by Binding to Cell Surface Heparan Sulfate Proteoglycan Receptors 2013
2013 Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes 2013
2013 Ribosomal protein S25 dependency reveals a common mechanism for diverse internal ribosome entry sites and ribosome shunting 2013
2012 Cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus. 2012
2012 Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. 2012
2012 Hepatitis C virus infects the endothelial cells of the blood-brain barrier 2012
2010 The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus. 2010
2009 Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. 2009
2009 Proteomics study of the hepatitis C virus replication complex. 2009
2007 Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. 2007
2007 Human serum amyloid A protein inhibits hepatitis C virus entry into cells. 2007
2006 Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. 2006
2006 The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA. 2006
2005 Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. 2005
2005 Heterologous RNA replication enhancer stimulates in vitro RNA synthesis and template-switching by the carmovirus, but not by the tombusvirus, RNA-dependent RNA polymerase: implication for modular evolution of RNA viruses. 2005
2005 Mutagenesis analysis of the rGTP-specific binding site of hepatitis C virus RNA-dependent RNA polymerase. 2005
2005 Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase. 2005
2004 Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell. 2004
2004 Orally active fusion inhibitor of respiratory syncytial virus. 2004
2003 Heterocyclic aminopyrrolidine derivatives as melatoninergic agents. 2003
2003 Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA. 2003
2003 Role of the 5'-proximal stem-loop structure of the 5' untranslated region in replication and translation of hepatitis C virus RNA. 2003
2002 Structure-activity relationships for a series of thiobenzamide influenza fusion inhibitors derived from 1,3,3-trimethyl-5-hydroxy-cyclohexylmethylamine. 2002
2001 An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology. 2001
2000 Salicylamide inhibitors of influenza virus fusion. 2000
2000 De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus. 2000
1999 Novel quinolizidine salicylamide influenza fusion inhibitors. 1999
1999 Conquering influenza: recent advances in anti-influenza drug discovery. 1999
1999 Cellular proteins bind to the poly(U) tract of the 3' untranslated region of hepatitis C virus RNA genome. 1999
1999 pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion. 1999
1997 Inhibition of influenza viral polymerases by minimal viral RNA decoys. 1997
1997 Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus. 1997
1996 Characterization of a hemagglutinin-specific inhibitor of influenza A virus. 1996

Full Name

  • Guangxiang Luo